PTN - Palatin Technologies Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PTN - Palatin Technologies Inc.

PTN 15.35

-0.2%

1:51 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (37)	6/1/2001 11:19:55 AM
From: scaram(o)uche	Read Replies (1) of 142

Don't know, but the phase I guinea pigs weren't barfing. One thing's for certain, your question is very, very, very, very important to answer! Palatin Chief Executive Officer and President Carl Spana, Ph.D. stated ``We are very pleased with the results of this study, which demonstrated a very positive safety profile for PT-141. The study generated significant data relating to the nasal absorption of PT-141 that gives us confidence that nasal delivery of the drug is a very viable commercial option. As a result, we are very excited about advancing the clinical development of PT-141 to a Phase 2 efficacy trial in patients with ED, which should begin in mid-2001.''

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next